Pretreatment Carcinoembryonic Antigen Level is a Risk Factor of Para-aortic Lymph Node Recurrence in Addition to Squamous Cell Carcinoma Antigen after Definitive Concurrent Chemoradiotherapy For Squamous Cell Carcinoma Of The Uterine Cervix

E Huang,C Wang,H Hsu,L Sun,C Chanchien,H Lin,H Chen,C Tseng,Y Ou,H Chang

doi:10.1016/j.ijrobp.2010.07.934

Pretreatment Carcinoembryonic Antigen Level is a Risk Factor of Para-aortic Lymph Node Recurrence in Addition to Squamous Cell Carcinoma Antigen after Definitive Concurrent Chemoradiotherapy For Squamous Cell Carcinoma Of The Uterine Cervix

E Huang, C Wang + Show 8 more

https://doi.org/10.1016/j.ijrobp.2010.07.934

Copy DOI

Journal: International Journal of Radiation Oncology, Biology, Physics	Publication Date: Sep 30, 2010
Citations: 25

Affiliation: Chang Gung Memorial Hospital

#Pretreatment Carcinoembryonic Antigen Level #Para-aortic Lymph Node Recurrence + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

To evaluate the pretreatment carcinoembryonic antigen (CEA) levels as a risk factor of para-aortic lymph node (PALN) recurrence in addition to squamous cell carcinoma antigen (SCC-Ag) levels following concurrent chemoradiotherapy (CCRT) for cervical cancer.

Full Text